News | Clinical Decision Support | October 11, 2017

ACR Appropriateness Criteria Add Topics, Increase Diagnostic Imaging Clinical Scenarios

Latest release features five new and seven revised topics, bringing total to 1,570 clinical scenarios

ACR Appropriateness Criteria Add Topics, Increase Diagnostic Imaging Clinical Scenarios

October 11, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR Appropriateness Criteria. The latest edition covers 178 diagnostic imaging and interventional radiology topics with 890 clinical variants. Diagnostic imaging topics now cover 1,570 clinical scenarios. 

This update from the American College of Radiology (ACR) includes five new and seven revised topics. Each topic has a narrative, an evidence table and a literature search summary. 

“These evidence-based guidelines define practice principles to ensure high-quality outcomes and patient safety,” said Frank J. Rybicki, M.D., Ph.D., FACR, chair of the ACR Committee on Appropriateness Criteria. “Using them encourages the proper choice of radiologic procedures to reduce both practice variation and performance of unwarranted procedures,” he added.

New topics are: 

Recently revised topics include:

ACR Appropriateness Criteria also address 61 radiation oncology topics — thus covering 235 unique topics. The guidelines are specified appropriate use criteria (AUC) under the Protecting Access to Medicare Act (PAMA) legislation. They are developed by expert panels of radiologists and other doctors from relevant medical specialties. The ACR is designated by the Centers for Medicare and Medicaid Services (CMS) as a qualified Provider-Led Entity. Medical providers may consult the ACR Appropriateness Criteria to fulfill PAMA requirements that they consult AUC prior to ordering advanced diagnostic imaging for Medicare patients.

Read the article "Clinical Decision Support Driving Small Reduction in Inappropriate Imaging Studies."

For more information: www.acr.org

Related Content

ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Sponsored Content | Videos | Imaging | February 15, 2018
Kiyotaka Fujii, global healthcare senior executive officer and president of Konica Minolta, discusses the company's...
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018
Patients and their caregivers desire information about upcoming imaging examinations, but many are not getting it,...
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Overlay Init